Michael T. Sweeney
Technik-/Wissenschafts-/F&E-Leiter bei RESVERLOGIX CORP.
Vermögen: 6 523 $ am 30.04.2024
Aktive Positionen von Michael T. Sweeney
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RESVERLOGIX CORP. | Technik-/Wissenschafts-/F&E-Leiter | 03.11.2014 | - |
Karriereverlauf von Michael T. Sweeney
Ehemalige bekannte Positionen von Michael T. Sweeney
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Technik-/Wissenschafts-/F&E-Leiter | 06.05.2009 | 01.01.2014 |
| Corporate Officer/Principal | 01.12.2007 | 06.05.2009 | |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2003 | 01.09.2007 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.1995 | 01.01.2003 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Corporate Officer/Principal | - | - |
Ausbildung von Michael T. Sweeney
| The University of Liverpool | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University of London | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
- Börse
- Insiders
- Michael T. Sweeney
- Erfahrung
